Bored Between the Holidays? Watch these Biotech Videos!
Christmas might have passed, but we have more videos for you to watch on a…
Christmas might have passed, but we have more videos for you to watch on a…
Still catching up on news? We've picked out the most exciting things that happened besides…
We love hearing from our readers, and we listen to what they like! Here are…
In a deal worth up to €23.6M, Summit Therapeutics licensed the commercialization of its new…
We've already named the best companies of the year, but which are our favorite companies? Here's…
LSP has closed a €280M fund, Health Economics Fund 2, that is dedicated to medtech…
ChemomAb kicked off its antibody efforts as a company in 2011, and its $10M Series…
Following alarming research about the safety of Sanofi's dengue vaccine, Dengvaxia, The Philippines has halted…
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
It isn't news that pharma's business model is in trouble, but a new report from…
Over 10,000 human diseases are caused by exactly one faulty gene. Gene therapy promises to fix…
Anne Portwich, Partner at venture capital firm LSP, told me about her career path and…